SA has one of the highest HIV burdens globally.
The country hopes to start rolling out Johnson & Johnson’s Covid-19 vaccine to health workers in a research study this week.
It has paused the use of AstraZeneca’s vaccine because preliminary data showed it offered minimal protection against mild to moderate illness from the country’s dominant coronavirus variant, 501Y.V2.